{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:12:04Z","timestamp":1790730724376,"version":"4.1.0"},"reference-count":68,"publisher":"Frontline Medical Communications, Inc.","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cutaneous Medicine and Surgery"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.sder.2011.04.004","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T18:43:14Z","timestamp":1311532994000},"page":"101-106","source":"Crossref","is-referenced-by-count":16,"title":["Approach to Pruritus in the Adult HIV-Positive Patient"],"prefix":"10.12788","volume":"30","author":[{"given":"Ser Ling Chua","family":"Serling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieron","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5043","reference":[{"key":"10.1016\/j.sder.2011.04.004_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1365-2133.2006.07430.x","article-title":"Pruritus as a leading symptom: Clinical characteristics and quality of life in German and Ugandan patients","volume":"155","author":"Weisshaar","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(96)01032-X","article-title":"HIV-related skin diseases","volume":"348","author":"Tschachler","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.04.004_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies","volume":"372","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.04.004_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0167-5699(93)90208-3","article-title":"A TH1\u2192TH2 switch is a critical step in the etiology of HIV infection","volume":"14","author":"Clerici","year":"1993","journal-title":"Immunol Today"},{"key":"10.1016\/j.sder.2011.04.004_bib5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00002030-199709000-00005","article-title":"Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry","volume":"11","author":"Klein","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.sder.2011.04.004_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archderm.1994.01690010125029","article-title":"Hypereosinophilia secondary to immunodysregulation in patients with HIV-1 disease","volume":"130","author":"Smith","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0091-6749(90)90154-V","article-title":"Serum IgE and human immunodeficiency virus (HIV) infection","volume":"85","author":"Wright","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.sder.2011.04.004_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0889-857X(02)00098-4","article-title":"Role of endogenous retroviruses in autoimmune diseases","volume":"29","author":"Perl","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.sder.2011.04.004_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archderm.1989.01670150047004","article-title":"Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus","volume":"125","author":"Coldiron","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2133.1997.tb03793.x","article-title":"The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression","volume":"137","author":"Uthayakumar","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1258\/ijsa.2009.009092","article-title":"Mucocutaneous manifestations in 150 HIV-infected Indian patients and their relationship with CD4 lymphocyte counts","volume":"20","author":"Sud","year":"2009","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.sder.2011.04.004_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1523-1747.1999.00508.x","article-title":"Depletion of cutaneous peptidergic innervation in HIV-associated xerosis","volume":"112","author":"Rowe","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mjd.2001.112350","article-title":"Prevalence and predictors of skin disease in the women's Interagency HIV Study (WIHS)","volume":"44","author":"Mirmirani","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11882-002-0050-x","article-title":"The relationship between HIV infection and atopic dermatitis","volume":"2","author":"Rudikoff","year":"2002","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.sder.2011.04.004_bib15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1086\/381264","article-title":"The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women","volume":"38","author":"Maurer","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.sder.2011.04.004_bib16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0190-9622(93)70234-K","article-title":"Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: A new association with intravenous drug abuse","volume":"29","author":"Kaplan","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1529-8019.2010.01371.x","article-title":"Diagnosis and treatment of cutaneous paraneoplastic disorders","volume":"23","author":"Velez","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.sder.2011.04.004_bib18","first-page":"1","article-title":"Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents","year":"2011"},{"key":"10.1016\/j.sder.2011.04.004_bib19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-110-11-937","article-title":"Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS)","volume":"110","author":"Gill","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sder.2011.04.004_bib20","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0190-9622(85)70243-5","article-title":"Seborrheic dermatitis in patients with acquired immunodeficiency syndrome","volume":"13","author":"Mathes","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000018087","article-title":"Is there a relation between risk groups or initial CD4 T cell counts and prevalence of seborrheic dermatitis in HIV-infected patients?","volume":"198","author":"Schaub","year":"1999","journal-title":"Dermatology (Basel)"},{"key":"10.1016\/j.sder.2011.04.004_bib22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(87)70257-6","article-title":"Dermatologic findings associated with human immunodeficiency virus infection","volume":"17","author":"Matis","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0190-9622(88)70174-7","article-title":"Mucocutaneous manifestations in patients infected with human immunodeficiency virus","volume":"19","author":"Alessi","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib24","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1046\/j.1365-2133.2000.03828.x","article-title":"Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis","volume":"143","author":"Pirkhammer","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib25","series-title":"From the Ground Up: Building Comprehensive HIV\/AIDS Program in Resource-Limited Settings","article-title":"Identification and management of cutaneous manifestations of HIV in adults and children","author":"Mosam","year":"2009"},{"key":"10.1016\/j.sder.2011.04.004_bib26","first-page":"280","article-title":"The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient-membership survey","volume":"137","author":"Krueger","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib27","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/archderm.1987.01660360050012","article-title":"Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome","volume":"123","author":"Duvic","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0190-9622(08)80033-3","article-title":"Zidovudine treatment of psoriasis associated with acquired immunodeficiency syndrome","volume":"22","author":"D\u00edez","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib29","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0190-9622(95)91338-6","article-title":"Zidovudine for the treatment of HIV-negative patients with psoriasis: A pilot study","volume":"32","author":"Townsend","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archderm.1997.03890420043005","article-title":"Acitretin therapy is effective for psoriasis associated with human immunodeficiency virus infection","volume":"133","author":"Buccheri","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0781.1999.tb00049.x","article-title":"HIV","volume":"15","author":"Akaraphanth","year":"1999","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.sder.2011.04.004_bib32","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archinternmed.2009.104","article-title":"Cutaneous malignancies among HIV-infected persons","volume":"169","author":"Crum-Cianflone","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sder.2011.04.004_bib33","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1473-3099(10)70101-8","article-title":"HIV-associated psoriasis: Pathogenesis, clinical features, and management","volume":"10","author":"Morar","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.sder.2011.04.004_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000424240","article-title":"Scabies: What's new?","volume":"22","author":"Orkin","year":"1995","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(99)09458-1","article-title":"Scabies and pediculosis","volume":"355","author":"Chosidow","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.04.004_bib36","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199306103282304","article-title":"Cutaneous disease and drug reactions in HIV infection","volume":"328","author":"Coopman","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sder.2011.04.004_bib37","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sder.2011.04.004_bib38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00130832-200108000-00006","article-title":"HIV and drug allergy","volume":"1","author":"Pirmohamed","year":"2001","journal-title":"Clin Opin Allergy Clin Immunol"},{"key":"10.1016\/j.sder.2011.04.004_bib39","first-page":"431","article-title":"Adverse reactions to co-tromoxazole in HIV infection","volume":"ii","author":"Van der Ven","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.04.004_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-200201040-00010","article-title":"Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy","volume":"16","author":"Dean","year":"2002","journal-title":"AIDS"},{"issue":"Suppl 1","key":"10.1016\/j.sder.2011.04.004_bib41","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/00126334-200309011-00004","article-title":"Defining the toxicity profile of nevirapine and other antiretroviral drugs","volume":"34","author":"Murphy","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.sder.2011.04.004_bib42","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0149-2918(01)80132-6","article-title":"Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir","volume":"23","author":"Hetherington","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.sder.2011.04.004_bib43","series-title":"Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy","first-page":"339","article-title":"Clinical risk factors for hypersensitivity reactions to abacavir: retrospective analysis of over 8,000 subjects receiving abacavir in 34 clinical trials","author":"Hernandez","year":"2003"},{"key":"10.1016\/j.sder.2011.04.004_bib44","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(02)08158-8","article-title":"Genetic variations in HLA-B region and hypersensitivity reactions to abacavir","volume":"359","author":"Hetherington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.04.004_bib45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.04.004_bib46","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B*5701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sder.2011.04.004_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0b013e318046ea31","article-title":"Prospective screening for human leucocyte antigen-B*5701 avoids abacavir hypersensitivity reaction in the ethnically mixed French HIV population","volume":"45","author":"Zucman","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.sder.2011.04.004_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(07)61049-6","article-title":"Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: A randomised controlled phase III trial","volume":"370","author":"Madruga","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.04.004_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000248985","article-title":"Eosinophilic pustular folliculitis","volume":"174","author":"Ofuji","year":"1987","journal-title":"Dermatologica"},{"key":"10.1016\/j.sder.2011.04.004_bib50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archderm.1991.01680020074008","article-title":"Human immunodeficiency virus-associated eosinophilic folliculitis","volume":"127","author":"Rosenthal","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib51","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archderm.1995.01690150124031","article-title":"Itraconazole therapy for human immunodeficiency virus-Associated eosinophilic folliculitis","volume":"131","author":"Berger","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib52","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archderm.1995.01690210077012","article-title":"Isotretinoin therapy for human immunodeficiency virus-associated eosinophilic folliculitis","volume":"131","author":"Otley","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib53","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0190-9622(97)70142-7","article-title":"UVB phototherapy is an effective treatment for pruritus in patients infected with HIV","volume":"37","author":"Lim","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archderm.1995.01690150126032","article-title":"Eosinophilic folliculitis associated with the acquired immunodeficiency syndrome responds well to permethrin","volume":"131","author":"Blauvelt","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib55","first-page":"117","article-title":"Generalized papular pruritic eruption in African patients with human immunodeficiency virus infection","volume":"1","author":"Colebunders","year":"1987","journal-title":"AIDS"},{"key":"10.1016\/j.sder.2011.04.004_bib56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archderm.125.5.629","article-title":"Pruritic skin lesions","volume":"125","author":"Liautaud","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib57","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-4362.1999.00694.x","article-title":"Pruritic papular eruption in HIV seropositive patients: A cutaneous marker for immunosuppression","volume":"38","author":"Boonchai","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib58","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1001\/jama.292.21.2614","article-title":"Etiology of pruritic papular eruption with HIV infection in Uganda","volume":"292","author":"Resneck","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.sder.2011.04.004_bib59","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/QAD.0b013e3282f313a9","article-title":"Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?","volume":"22","author":"Castelnuovo","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.sder.2011.04.004_bib60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-4632.2009.04279.x","article-title":"Antihistamines are superior to topical steroids in managing human immunodeficiency virus (HIV)-associated papular pruritic eruption","volume":"49","author":"Navarini","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib61","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.clindermatol.2004.07.007","article-title":"Cutaneous markers of HIV infection","volume":"22","author":"Rigopoulos","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000245987","article-title":"Pruritus in HIV-1 disease: Therapy with drugs which may modulate the pattern of immune dysregulation","volume":"195","author":"Smith","year":"1997","journal-title":"Dermatology (Basel)"},{"key":"10.1016\/j.sder.2011.04.004_bib63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0781.2004.00101.x","article-title":"Clinical and epidemiologic characterization of photosensitivity in HIV-positive individuals","volume":"20","author":"Bilu","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.sder.2011.04.004_bib64","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1346-8138.2000.tb02185.x","article-title":"Photosensitivity in HIV-infected individuals","volume":"27","author":"Vin-Christian","year":"2000","journal-title":"J Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib65","series-title":"Guidelines on Co-Trimoxazole Prophylaxis for HIV-Related Infections Among Children, Adolescents and Adults in Resource-Limited Settings: Recommendations for a Public Health Approach","year":"2006"},{"key":"10.1016\/j.sder.2011.04.004_bib66","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaad.2009.08.052","article-title":"Antipruritic treatment with systemic \u03bc-opioid receptor antagonists: A review","volume":"63","author":"Phan","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib67","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archderm.140.7.845","article-title":"Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: Efficacy and risk of neuropathy","volume":"140","author":"Maurer","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.04.004_bib68","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000245988","article-title":"Sequential combined therapy with thalidomide and narrow-band (TL01) UVB in the treatment of prurigo nodularis","volume":"195","author":"Ferr\u00e1ndiz","year":"1997","journal-title":"Dermatology (Basel)"}],"container-title":["Seminars in Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562911000496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562911000496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scmsjournal.com\/wp-content\/uploads\/2016\/01\/Vol30_i2-Chua.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T15:07:08Z","timestamp":1616166428000},"score":1,"resource":{"primary":{"URL":"http:\/\/scmsjournal.com\/article\/buy_now\/?id=171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1085562911000496"],"URL":"https:\/\/doi.org\/10.1016\/j.sder.2011.04.004","relation":{},"ISSN":["1085-5629"],"issn-type":[{"value":"1085-5629","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}